Call from Friday December 19th, featuring Dr. Anne Yacoub.

Anne Damian Yacoub, M.D., is a neurologist who specializes in both multiple sclerosis and headache. Her areas of expertise include the diagnosis and treatment of multiple sclerosis and other neuroimmunological disorders that involve the central nervous system. She is also an expert in acute and chronic management of headache disorders.

Dr. Yacoub earned her medical degree from the University of Arizona College of Medicine, followed by a residency in neurology at the McGill University Health Centre. Dr. Yacoub spent one year studying the diagnosis and management of headaches as a Seymour Diamond Headache Medicine fellow in a combined program at the Diamond Headache Clinic and the Loyola University Medical Center in Chicago. She subsequently trained as a clinical and research fellow in the Johns Hopkins Department of Neurology, studying neuroimmunology and neurological infections.

Dr. Yacoub's research interests include studying migraine headaches in patients with multiple sclerosis.

Call from Friday December 12th, featuring Dr. Michael Streiff.

Dr. Streiff's major clinical interest involves the prevention and treatment of venous thromboembolism. He has written several comprehensive reviews on vena caval filters and the management of venous thromboembolism in cancer patients. He chairs the Venous Thromboembolism Guideline Committee for the National Comprehensive Cancer Center Network and has served on international consensus panels to develop standardized guidelines for the use of vena caval filters in the management of venous thromboembolism. As a member of a Johns Hopkins Evidence-Based Practice Center panel, he participated in the development of evidence reports on the management of venous thromboembolism.

As Medical Director of the Anticoagulation Management Service and Outpatient Clinics, he and his colleagues from the Department of Pharmacy have been actively involved in developing policies and procedures for standardizing anticoagulation management and guidelines for VTE prevention at the Johns Hopkins Medical Institutions. As the consulting Hematologist for the Johns Hopkins Comprehensive Hemophilia Treatment Center, he is actively involved in the diagnosis and treatment of patients with hemophilia, von Willebrand disease and other hemostatic disorders.

Call from Friday December 5th, 2025 featuring Dr. Otis Brawley.

Otis Brawley is a globally-recognized expert in cancer prevention and control. He has worked to reduce overscreening of medical conditions, which has revolutionized patient treatment by increasing quality of life and reducing health disparities.

Brawley's research focuses on developing cancer screening strategies and ensuring their effectiveness. He has championed efforts to decrease smoking and implement other lifestyle risk reduction programs, as well as to provide critical support to cancer patients and concentrate cancer control efforts in areas where they could be most effective. Brawley currently leads a broad interdisciplinary research effort on cancer health disparities at the Bloomberg School of Public Health and the Johns Hopkins Kimmel Cancer Center, striving to close racial, economic, and social disparities in the prevention, detection, and treatment of cancer in the United States and worldwide. He also directs community outreach programs for underserved populations throughout Maryland.